Cadence Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cadence Pharmaceuticals ( CADX) is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing products principally for use in the hospital setting. This stock is trading up 7.6% at $3.95 in recent trading.

Today's Range: $3.56-$3.99

52-Week Range: $2.56-$9.27

Volume: 160,000

Three-Month Average Volume: 375,129

>>5 Health Care Stocks Setting Up to Break Out

From a technical perspective, CADX is ripping higher here with light volume, and the stock has moved into near-term breakout territory since the stock has taken out resistance at $3.70 to $3.88.

Traders should now look for long-biased trades once CADX moves above its 200-day moving average of $4.08 with high volume. Look for a sustained move or close above that level with volume that's near or above 375,129 shares. If we get that action soon, then CADX should re-test and possibly take out its next significant overhead resistance levels at $4.37 to $4.63. If those levels are then taken out with volume, CADX could spike toward $5 to $6 in the near future.

On the flipside, I would avoid CADX if it fails to maintain a strong volume trend back above its 200-day.

If you liked this article you might like

Most Restaurant Stocks Remain Tough to Swallow

6 Stocks That Could Get a Bump From Glenn Welling

5 Stocks With Big Insider Buying

Ranking the Activists for Proxy Season 2016

These 5 Stocks Are Set to Soar on Bullish Earnings